These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The role of surface charge in the interaction of nanoparticles with model pulmonary surfactants. Mousseau F; Berret JF Soft Matter; 2018 Jul; 14(28):5764-5774. PubMed ID: 29989135 [TBL] [Abstract][Full Text] [Related]
9. Nanoparticles in the lung and their protein corona: the few proteins that count. Whitwell H; Mackay RM; Elgy C; Morgan C; Griffiths M; Clark H; Skipp P; Madsen J Nanotoxicology; 2016 Nov; 10(9):1385-94. PubMed ID: 27465202 [TBL] [Abstract][Full Text] [Related]
11. On the rheology of pulmonary surfactant: Effects of concentration and consequences for the surfactant replacement therapy. Thai LPA; Mousseau F; Oikonomou EK; Berret JF Colloids Surf B Biointerfaces; 2019 Jun; 178():337-345. PubMed ID: 30897431 [TBL] [Abstract][Full Text] [Related]
12. Phosphonate coating of SiO Großgarten M; Holzlechner M; Vennemann A; Balbekova A; Wieland K; Sperling M; Lendl B; Marchetti-Deschmann M; Karst U; Wiemann M Part Fibre Toxicol; 2018 Jul; 15(1):31. PubMed ID: 30012173 [TBL] [Abstract][Full Text] [Related]
13. Effect of contact angle, zeta potential and particles size on the in vitro studies of Al2O3 and SiO2 nanoparticles. Karunakaran G; Suriyaprabha R; Rajendran V; Kannan N IET Nanobiotechnol; 2015 Feb; 9(1):27-34. PubMed ID: 25650323 [TBL] [Abstract][Full Text] [Related]
14. High-resolution investigation of nanoparticle interaction with a model pulmonary surfactant monolayer. Sachan AK; Harishchandra RK; Bantz C; Maskos M; Reichelt R; Galla HJ ACS Nano; 2012 Feb; 6(2):1677-87. PubMed ID: 22288983 [TBL] [Abstract][Full Text] [Related]
15. Interfacial molecular imprinting of Stöber particle surfaces: a simple approach to targeted saccharide adsorption. Joshi S; Rao A; Lehmler HJ; Knutson BL; Rankin SE J Colloid Interface Sci; 2014 Aug; 428():101-10. PubMed ID: 24910041 [TBL] [Abstract][Full Text] [Related]
16. Interaction of metal oxide nanoparticles with lung surfactant protein A. Schulze C; Schaefer UF; Ruge CA; Wohlleben W; Lehr CM Eur J Pharm Biopharm; 2011 Apr; 77(3):376-83. PubMed ID: 21056657 [TBL] [Abstract][Full Text] [Related]
17. Dialysis process for the removal of surfactants to form colloidal mesoporous silica nanoparticles. Urata C; Aoyama Y; Tonegawa A; Yamauchi Y; Kuroda K Chem Commun (Camb); 2009 Sep; (34):5094-6. PubMed ID: 20448957 [TBL] [Abstract][Full Text] [Related]
18. Lung surfactants and different contributions to thin film stability. Hermans E; Bhamla MS; Kao P; Fuller GG; Vermant J Soft Matter; 2015 Nov; 11(41):8048-57. PubMed ID: 26307946 [TBL] [Abstract][Full Text] [Related]
19. Alteration of biophysical activity of pulmonary surfactant by aluminosilicate nanoparticles. Kondej D; Sosnowski TR Inhal Toxicol; 2013 Feb; 25(2):77-83. PubMed ID: 23363039 [TBL] [Abstract][Full Text] [Related]